🇺🇸 FDA
Patent

US 11225514

Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)

granted A61KA61K31/166

Quick answer

US patent 11225514 (Nanobodies against cystic fibrosis transmembrane conductance regulator (CFTR) inhibitory factor (Cif)) held by The Regents of the University of California expires Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jan 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K31/166